Ophthalmic features of cone‐rod dystrophy caused by pathogenic variants in the ALMS1 gene. Issue 4 (30th November 2017)

• Record Type: Journal Article
• Authors: Nasser, Fadi; Weisschuh, Nicole; Maffei, Pietro; Milan, Gabriella; Heller, Corina; Zrenner, Eberhart; Kohl, Susanne; Kuehlewein, Laura
• Is Part Of: Acta ophthalmologica. Volume 96:Issue 4(2018)
• Page Start: e445
• Page End: e454
• Publication Date: 2017-11-30
• Subjects: ALMS1 -- Alström Syndrome -- Cone‐rod dystrophy -- hereditary retinal degeneration; Ophthalmology -- Periodicals; 617.7005
• DOI: 10.1111/aos.13612
• Languages: English
• ISSNs: 1755-375X

Abstract

Abstract: Purpose: We aim to describe ophthalmic characteristics and systemic findings in a cohort of seven patients with cone‐rod retinal dystrophy (CORD) caused by pathogenic variants in the ALMS1 gene. Methods: Seven patients with Alström syndrome (ALMS) were included in the study. A comprehensive ophthalmological examination was performed, including best‐corrected visual acuity (BCVA), a semiautomated kinetic visual field exam, colour vision testing, full‐field electroretinography testing according to International Society for Clinical Electrophysiology of Vision (ISCEV) standards, spectral domain optical coherence tomography (SD‐OCT) and fundus autofluorescence (FAF) imaging, and slit lamp and dilated fundus examination. DNA samples were analysed using Sanger sequencing or exome sequencing. Results: In our cohort, the ocular phenotype presented with a wide variability in retinal function and disease severity. However, age of symptom onset (i.e. nystagmus and photophobia) was at 6–9 months in all patients. These symptoms mostly mislead to the diagnosis of congenital achromatopsia (ACHM), Leber congenital amaurosis (LCA), isolated CORD or Bardet–Biedl syndrome. The systemic manifestations in our cohort were highly variable. Conclusion: In summary, we can report that most of our ALMS patients primarily presented with nystagmus and severe photophobia since early childhood interestingly without night blindness in the absence of systemic symptoms. Only genetic testing analysing both nonsyndromic retinal disease (RD) genes and syndromic ciliopathy genes by comprehensive panel sequencing can result in the correct diagnosis, genetically and clinically, with important implication for the physical health of the individual.